Regenerx Biopharmaceuticals INC
SEC CIK 707511 · RGRX.OB · last insider filing 2023-07-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Finkelstein J J | Director · President and CEO | filed 2006 - 2022 |
| Mcnay Joseph C | Director | filed 2007 - 2022 |
| Elsey R Don | Director | filed 2010 - 2022 |
| Bove Mauro | Director | filed 2007 - 2022 |
| Noseda Alessandro | Director | filed 2019 - 2022 |
| Goldstein Allan L | Director · President and CEO | filed 2007 - 2022 |
| Bowles L Thompson | Director | filed 2006 - 2014 |
| Hindin Richard J | Director | filed 2007 - 2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Saglio Dane R | Chief Financial Officer | filed 2014 - 2014 |
| Crockford David | VP of Clinical and Reg Affairs | filed 2007 - 2012 |
| Lyons C Neil | CFO and Treasurer | filed 2007 - 2010 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.